• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS ALBT2 TINA-QUANT ALBUMIN GEN.2; ALBUMIN IMMUNOLOGICAL TEST SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS ALBT2 TINA-QUANT ALBUMIN GEN.2; ALBUMIN IMMUNOLOGICAL TEST SYSTEM Back to Search Results
Catalog Number 04469658190
Device Problem High Test Results (2457)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 04/15/2021
Event Type  malfunction  
Manufacturer Narrative
The field service engineer checked probe alignments and pump pressures.The gear pump and wash pump pressures were adjusted.The microalbumin test was calibrated and precision studies were performed; results were within specification.The customer repeated the samples in question and results measured with the new lot of reagent were very close, but these did not match the results obtained with the old lot.The last calibration performed on (b)(6) 2021 with lot 515982 was not ok and had an error.Quality controls were outside of range for reagent lot 515982.The customer confirmed the assay is now working as expected after the service actions and a different reagent lot was installed.The investigation determined the issue was resolved by these actions.Medwatch field udi number (b)(4).
 
Event Description
The initial reporter stated they started using a new lot number of albt2 tina-quant albumin gen.2 (microalbumin, lot 51598201, expiration date = 31-aug-2022) on the cobas 6000 c (501) module and had multiple failed calibration attempts.Calibration then was successful, but controls were outside of range.The customer pulled patient urine samples that were initially tested using old microalbumin reagent lot 497736 (expiration date unknown) and then tested these using the new lot 51598201.A new shipment of new lot 51598201 was sent to the customer and calibration and controls tested with this reagent passed.The patient urine samples were also tested using this new shipment.There were discrepancies in the results for six patient samples.All initial results measured with the old lot number were reported outside of the laboratory.Refer to the attachment for all patient data.The serial number of the c 501 analyzer is (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ALBT2 TINA-QUANT ALBUMIN GEN.2
Type of Device
ALBUMIN IMMUNOLOGICAL TEST SYSTEM
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
Manufacturer (Section G)
ROCHE DIAGNOSTICS GMBH
sandhoferstrasse 116
na
mannheim (baden-wurttemberg) 68305
GM   68305
Manufacturer Contact
michael leslie
9115 hague road
na
indianapolis, IN 46250
3175214343
MDR Report Key11778556
MDR Text Key250198269
Report Number1823260-2021-01360
Device Sequence Number1
Product Code DCF
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K101203
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,user faci
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 05/05/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/05/2021
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date08/31/2022
Device Catalogue Number04469658190
Device Lot Number51598201, 497736
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Date Manufacturer Received04/16/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Age66 YR
Patient Weight131
-
-